Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV Vaccines Immunogenicity and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05518201
What this trial is testing

Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old

Who this might be right for
Penile CancerAnal CancerPIN-1+6 more
Shanghai Bovax Biotechnology Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT00513526
What this trial is testing

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

Who this might be right for
InfectionPrecancerous Condition
AIDS Malignancy Consortium 112
Large-scale testing (Phase 3)Study completedNCT04635423
What this trial is testing

Efficacy, Immunogenicity, and Safety Study of V503 (9-valent Human Papillomavirus [9vHPV] Vaccine) in Japanese Males (V503-064)

Who this might be right for
Warts, GenitalNeoplasms, Anal
Merck Sharp & Dohme LLC 1,059
Early research (Phase 1)Looking for participantsNCT07081984
What this trial is testing

Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors

Who this might be right for
HPV 16+ Recurrent or Metastatic CancerHNSCCCervical Cancer
Therorna 12
Large-scale testing (Phase 3)Study completedNCT00518180
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents

Who this might be right for
Meningococcal MeningitisHuman Papillomavirus InfectionPertussis+1 more
Novartis Vaccines 1,620
Large-scale testing (Phase 3)Study completedNCT00196937
What this trial is testing

Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 667
Large-scale testing (Phase 3)Study completedNCT00345878
What this trial is testing

Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 271
Large-scale testing (Phase 3)Study completedNCT00092482
What this trial is testing

Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 3,882
Very early researchLooking for participantsNCT05208710
What this trial is testing

PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers

Who this might be right for
HPV
German Cancer Research Center 45
Large-scale testing (Phase 3)Study completedNCT00996125
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus 580299 Vaccine in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 750
Testing effectiveness (Phase 2)Study completedNCT02740790
What this trial is testing

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females

Who this might be right for
Human Papillomavirus
Shanghai Zerun Biotechnology Co.,Ltd 1,200
Large-scale testing (Phase 3)Looking for participantsNCT05262010
What this trial is testing

A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

Who this might be right for
HPV InfectioNHPV-Related Carcinoma
National Vaccine and Serum Institute, China 13,500
Large-scale testing (Phase 3)Study completedNCT03903562
What this trial is testing

Immunobridging Study of 9- Valent Human Papillomavirus (9vHPV) Vaccine (V503) in Chinese Females 9 to 45 Years of Age (V503-024)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 1,990
Large-scale testing (Phase 3)Study completedNCT00485732
What this trial is testing

Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 225
Not applicableUnknownNCT00666107
What this trial is testing

Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men

Who this might be right for
Anal CancerHIV Infections
Southern California Institute for Research and Education 150
Large-scale testing (Phase 3)Study completedNCT00316706
What this trial is testing

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

Who this might be right for
Cervical Intraepithelial NeoplasiaPapillomavirus Infection
GlaxoSmithKline 1,245
Early research (Phase 1)Ended earlyNCT02689726
What this trial is testing

Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL

Who this might be right for
HPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSIL
Genticel 13
Large-scale testing (Phase 3)Study completedNCT00092534
What this trial is testing

Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 12,167
Testing effectiveness (Phase 2)Study completedNCT06007092
What this trial is testing

Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer

Who this might be right for
Head and Neck CarcinomaAdult Disease
Gustave Roussy, Cancer Campus, Grand Paris 24
Early research (Phase 1)Study completedNCT03676101
What this trial is testing

Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancersVulvar CancerVaginal Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 90
Next Page